340 chapters · 3,787 sections in this title.
Ind. Code § 16-41-23-1 Sexual discrimination prohibited
0.3K chars
Sec. 1. An establishment that maintains restrooms for use by the public may not discriminate in charges required for facilities used by men and facilities used by women. [Pre-1993 Recodification Citation: 16-1-20.5-1.] As added by P.L.2-1993, SEC.24.
Ind. Code § 16-41-23-2 Coin lock controls; free toilet units
0.4K chars
Sec. 2. (a) As used in this section, "toilet units" means commodes and urinals. (b) When coin lock controls are used in public restrooms: (1) at least one-half (1/2) of the toilet units must be free of charge; and (2) the number of free toilet units available to women must equal …
Ind. Code § 16-41-23-3 Admission keys
0.3K chars
Sec. 3. If coin locks are placed on entry doors of public restrooms: (1) admission keys must be readily provided without charge when requested; and (2) notice as to the availability of the admission keys must be posted on the restroom entry door. [Pre-1993 Recodification Citation…
Ind. Code § 16-41-23-4 Violations
0.3K chars
Sec. 4. (a) Except as otherwise provided, a person who recklessly violates or fails to comply with this chapter commits a Class B misdemeanor. (b) Each day a violation continues constitutes a separate offense. [Pre-1993 Recodification Citation: 16-1-35-1.] As added by P.L.2-1993,…
Ind. Code § 16-42-23-1 Health care facilities; restrictions on use
0.7K chars
Sec. 1. Except as provided in section 8 of this chapter, a hospital or other health care facility may not interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin (laetrile) as an adjunct to recognized, customary, or accepted modes of th…
Ind. Code § 16-42-23-2 Disciplinary action against attending physician
0.5K chars
Sec. 2. A physician may not be subjected to disciplinary action by the medical licensing board of Indiana for prescribing or administering amygdalin (laetrile) to a patient under the physician's care as an adjunct to recognized, customary, or accepted modes of therapy in the trea…
Ind. Code § 16-42-23-3 Prescription or administration permitted with written
0.4K chars
informed request Sec. 3. A physician may prescribe or administer amygdalin (laetrile) instead of or in addition to customary or accepted modes of therapy in the treatment of a malignancy, a disease, an illness, or a physical condition of a patient who has signed the written infor…
Ind. Code § 16-42-23-4 Construction of chapter
0.5K chars
Sec. 4. (a) This chapter does not constitute an endorsement of amygdalin (laetrile) for the treatment of a malignancy, a disease, an illness, or a physical condition. (b) This chapter does not prevent a physician from prescribing amygdalin (laetrile) as a dietary supplement to a …
Ind. Code § 16-42-23-5 Written informed request form
2.3K chars
Sec. 5. (a) The written informed request must be on a form prepared by and obtained from the medical licensing board of Indiana and must be in substance as follows: WRITTEN INFORMED REQUEST FOR PRESCRIPTION OF AMYGDALIN (LAETRILE) FOR MEDICAL TREATMENT Patient's name ____________…
Ind. Code § 16-42-23-6 Regulation of use, sale, prescription, manufacture, or
1.1K chars
distribution within state Sec. 6. (a) Amygdalin (laetrile) is not a drug or a controlled substance under Indiana statutes governing the use, manufacture, or distribution of drugs and controlled substances within Indiana. (b) A physician may prescribe amygdalin (laetrile) under th…
Ind. Code § 16-42-23-7 Required manufacture, sale, distribution, or prescription
0.4K chars
Sec. 7. (a) This chapter does not require a: (1) physician; (2) pharmacist; (3) pharmacy; (4) manufacturer; or (5) distributor; to manufacture, sell, or distribute amygdalin (laetrile). (b) This chapter does not require a physician to prescribe amygdalin (laetrile) for a patient.…
Ind. Code § 16-42-23-8 Federal funding of health care facilities
0.9K chars
Sec. 8. If: (1) the federal government indicates that the federal government will withdraw all federal funds from a health care facility for allowing amygdalin (laetrile) to be used within the facility; and (2) providing or allowing use of amygdalin (laetrile) within the facility…